153 related articles for article (PubMed ID: 29635632)
1. A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients.
Inoue S; Saito Y; Tsuneto S; Aruga E; Ogata T; Uemori M
Jpn J Clin Oncol; 2018 May; 48(5):442-449. PubMed ID: 29635632
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
Inoue S; Saito Y; Tsuneto S; Aruga E; Takahashi H; Uemori M
Jpn J Clin Oncol; 2018 Jun; 48(6):542-547. PubMed ID: 29659913
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief).
Inoue S; Saito Y; Tsuneto S; Aruga E; Ide A; Kakurai Y
J Pain Res; 2017; 10():1953-1962. PubMed ID: 28860850
[TBL] [Abstract][Full Text] [Related]
6. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
[TBL] [Abstract][Full Text] [Related]
7. Satisfactory analgesia with minimal emesis in day surgeries: a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Vanniyasingam T; Devereaux PJ; Bhandari M; Thabane L
Br J Anaesth; 2019 Jun; 122(6):e107-e113. PubMed ID: 31027915
[TBL] [Abstract][Full Text] [Related]
8. Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Devereaux PJ; Bhandari M; Thabane L
BMJ Open; 2018 Jun; 8(6):e022504. PubMed ID: 29934395
[TBL] [Abstract][Full Text] [Related]
9. Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial.
Zeng X; Zhu J; Li J; Chen C; Sang L; Liu M; Song L; Liu H
J Pain Symptom Manage; 2024 Jan; 67(1):50-58. PubMed ID: 37742793
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation.
Coda BA; O'Sullivan B; Donaldson G; Bohl S; Chapman CR; Shen DD
Pain; 1997 Sep; 72(3):333-46. PubMed ID: 9313274
[TBL] [Abstract][Full Text] [Related]
11. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Wirz S; Wartenberg HC; Nadstawek J
Support Care Cancer; 2008 Sep; 16(9):999-1009. PubMed ID: 18095008
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial.
Ma K; Jin Y; Wang L; Feng ZY; Song T; Yang XQ; Chen FQ; Duan BL; Huang YQ; Xie GL; Bao HG; Wang K; Xu JT; Lu Y; Liu YQ
Pain; 2020 Nov; 161(11):2502-2510. PubMed ID: 32569090
[TBL] [Abstract][Full Text] [Related]
13. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
Palangio M; Northfelt DW; Portenoy RK; Brookoff D; Doyle RT; Dornseif BE; Damask MC
J Pain Symptom Manage; 2002 May; 23(5):355-68. PubMed ID: 12007754
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial.
Chang AK; Bijur PE; Meyer RH; Kenny MK; Solorzano C; Gallagher EJ
Ann Emerg Med; 2006 Aug; 48(2):164-72. PubMed ID: 16857467
[TBL] [Abstract][Full Text] [Related]
15. Hydromorphone.
Pasero C; McCaffery M
Am J Nurs; 2001 Feb; 101(2):22-3. PubMed ID: 11227223
[No Abstract] [Full Text] [Related]
16. Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain.
Wallace M; Rauck RL; Moulin D; Thipphawong J; Khanna S; Tudor IC
J Int Med Res; 2008; 36(2):343-52. PubMed ID: 18380946
[TBL] [Abstract][Full Text] [Related]
17. Epidural morphine vs hydromorphone in post-caesarean section patients.
Halpern SH; Arellano R; Preston R; Carstoniu J; O'Leary G; Roger S; Sandler A
Can J Anaesth; 1996 Jun; 43(6):595-8. PubMed ID: 8773867
[TBL] [Abstract][Full Text] [Related]
18. Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies.
Nalamachu SR; Kutch M; Hale ME
J Pain Symptom Manage; 2012 Dec; 44(6):852-65. PubMed ID: 22795050
[TBL] [Abstract][Full Text] [Related]
19. Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma.
MacKenzie M; Zed PJ; Ensom MH
Ann Pharmacother; 2016 Mar; 50(3):209-18. PubMed ID: 26739277
[TBL] [Abstract][Full Text] [Related]
20. Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery.
Goodarzi M
Paediatr Anaesth; 1999; 9(5):419-22. PubMed ID: 10447905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
